Tuesday afternoon, the U.S. District Court for the Southern District of Indiana ruled in favor of Cook Medical Incorporated and dismissed a patent infringement lawsuit filed by Endotach LLC, a subsidiary of the patent assertion entity Acacia Research Corporation. The lawsuit stated the various Cook stent grafts sold under the Zenith® brand infringed on patents that were allegedly licensed exclusively to Endotach.
Costs of litigation and threats of infringement allegations can hinder innovation and deny patients’ access to important new products.
“We are committed to defending our products against unsupported claims of patent infringement,” said Cynthia Kretz, Cook’s vice president and general counsel. “From day one, we vigorously defended this case, remaining confident in our defenses and determined to uphold the law,” added Ms. Kretz.
About Cook Medical
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world's healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at www.cookmedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn.
